Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Acute Heart Failure (AHF) Therapeutics Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Acute Heart Failure (AHF) Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Acute Heart Failure (AHF) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 B-Blockers
    • 1.4.3 Calcium Channel Blockers
    • 1.4.4 Cardiac Glycosides
    • 1.4.5 Diuretics
    • 1.4.6 Morphine
    • 1.4.7 Vasodilators/Nitrates
    • 1.4.8 Others
  • 1.5 Market by Application
    • 1.5.1 Global Acute Heart Failure (AHF) Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Home Care
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Acute Heart Failure (AHF) Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Acute Heart Failure (AHF) Therapeutics Growth Trends by Regions
    • 2.2.1 Acute Heart Failure (AHF) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Acute Heart Failure (AHF) Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Acute Heart Failure (AHF) Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Acute Heart Failure (AHF) Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Acute Heart Failure (AHF) Therapeutics Players by Market Size
    • 3.1.1 Global Top Acute Heart Failure (AHF) Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Acute Heart Failure (AHF) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Acute Heart Failure (AHF) Therapeutics Market Concentration Ratio
    • 3.2.1 Global Acute Heart Failure (AHF) Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Acute Heart Failure (AHF) Therapeutics Revenue in 2019
  • 3.3 Acute Heart Failure (AHF) Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Acute Heart Failure (AHF) Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Acute Heart Failure (AHF) Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Acute Heart Failure (AHF) Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
  • 6.2 Acute Heart Failure (AHF) Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
  • 7.2 Acute Heart Failure (AHF) Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
  • 8.2 Acute Heart Failure (AHF) Therapeutics Key Players in China (2019-2020)
  • 8.3 China Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
  • 9.2 Acute Heart Failure (AHF) Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
  • 10.2 Acute Heart Failure (AHF) Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
  • 11.2 Acute Heart Failure (AHF) Therapeutics Key Players in India (2019-2020)
  • 11.3 India Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Acute Heart Failure (AHF) Therapeutics Market Size (2015-2020)
  • 12.2 Acute Heart Failure (AHF) Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Bayer AG
    • 13.1.1 Bayer AG Company Details
    • 13.1.2 Bayer AG Business Overview
    • 13.1.3 Bayer AG Acute Heart Failure (AHF) Therapeutics Introduction
    • 13.1.4 Bayer AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020))
    • 13.1.5 Bayer AG Recent Development
  • 13.2 Bristol-Myers Squibb Company
    • 13.2.1 Bristol-Myers Squibb Company Company Details
    • 13.2.2 Bristol-Myers Squibb Company Business Overview
    • 13.2.3 Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Introduction
    • 13.2.4 Bristol-Myers Squibb Company Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
    • 13.2.5 Bristol-Myers Squibb Company Recent Development
  • 13.3 Cardiorentis AG
    • 13.3.1 Cardiorentis AG Company Details
    • 13.3.2 Cardiorentis AG Business Overview
    • 13.3.3 Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Introduction
    • 13.3.4 Cardiorentis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
    • 13.3.5 Cardiorentis AG Recent Development
  • 13.4 CVie Therapeutics Limited
    • 13.4.1 CVie Therapeutics Limited Company Details
    • 13.4.2 CVie Therapeutics Limited Business Overview
    • 13.4.3 CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Introduction
    • 13.4.4 CVie Therapeutics Limited Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
    • 13.4.5 CVie Therapeutics Limited Recent Development
  • 13.5 Cytokinetics, Inc.
    • 13.5.1 Cytokinetics, Inc. Company Details
    • 13.5.2 Cytokinetics, Inc. Business Overview
    • 13.5.3 Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Introduction
    • 13.5.4 Cytokinetics, Inc. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
    • 13.5.5 Cytokinetics, Inc. Recent Development
  • 13.6 Merck & Co.
    • 13.6.1 Merck & Co. Company Details
    • 13.6.2 Merck & Co. Business Overview
    • 13.6.3 Merck & Co. Acute Heart Failure (AHF) Therapeutics Introduction
    • 13.6.4 Merck & Co. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
    • 13.6.5 Merck & Co. Recent Development
  • 13.7 Novartis AG
    • 13.7.1 Novartis AG Company Details
    • 13.7.2 Novartis AG Business Overview
    • 13.7.3 Novartis AG Acute Heart Failure (AHF) Therapeutics Introduction
    • 13.7.4 Novartis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
    • 13.7.5 Novartis AG Recent Development
  • 13.8 Orion Corporation
    • 13.8.1 Orion Corporation Company Details
    • 13.8.2 Orion Corporation Business Overview
    • 13.8.3 Orion Corporation Acute Heart Failure (AHF) Therapeutics Introduction
    • 13.8.4 Orion Corporation Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
    • 13.8.5 Orion Corporation Recent Development
  • 13.9 PhaseBio Pharmaceuticals, Inc
    • 13.9.1 PhaseBio Pharmaceuticals, Inc Company Details
    • 13.9.2 PhaseBio Pharmaceuticals, Inc Business Overview
    • 13.9.3 PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Introduction
    • 13.9.4 PhaseBio Pharmaceuticals, Inc Revenue in Acute Heart Failure (AHF) Therapeutics Business (2015-2020)
    • 13.9.5 PhaseBio Pharmaceuticals, Inc Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Acute Heart Failure (AHF) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Heart Failure (AHF) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Bayer AG
    Bristol-Myers Squibb Company
    Cardiorentis AG
    CVie Therapeutics Limited
    Cytokinetics, Inc.
    Merck & Co.
    Novartis AG
    Orion Corporation
    PhaseBio Pharmaceuticals, Inc

    Market segment by Type, the product can be split into
    B-Blockers
    Calcium Channel Blockers
    Cardiac Glycosides
    Diuretics
    Morphine
    Vasodilators/Nitrates
    Others
    Market segment by Application, split into
    Hospital
    Clinic
    Home Care

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now